Related Experiment Videos

Conversion of threonine 757 to valine enhances Stat5a transactivation potential

P M Gowri1, T C Ganguly, J Cao

  • 1Graduate Center for Toxicology, University of Kentucky, Lexington 40536-0305, USA.

Insights

The growth hormone signaling pathway involves the Jak2-Stat5 pathway. Researchers found that mutating Thr(757) in Stat5a enhanced its transcriptional activity, suggesting this residue regulates Stat5 function.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Genetics

Background:

  • Growth hormone family cytokines signal via the Jak2-Stat5 pathway.
  • Stat5 C-termini regulate transactivation, phosphorylation, and DNA binding.

Purpose of the Study:

  • Investigate the role of Thr(757) in Stat5a's C-terminus.
  • Examine effects of Thr(757) mutations on nuclear translocation, DNA binding, and transcriptional activation.

Main Methods:

  • Mutagenesis of Thr(757) in Stat5a to Val and Asp.
  • Assessed prolactin-induced transcriptional activation using a Stat5-responsive luciferase reporter gene.
  • Analyzed nuclear translocation, DNA binding, and phosphorylation kinetics.

Main Results:

  • Val-Stat5a exhibited a 5-fold increase in transcriptional activity compared to wild-type Thr-Stat5a.
  • Asp-Stat5a showed similar activity to Thr-Stat5a.
  • Dephosphorylation pathways and kinetics were unaltered between Val- and Thr-Stat5a.
  • Serine-threonine kinase inhibitor H7 equally inhibited all Stat5 variants, ruling out Thr(757) phosphorylation as a regulatory mechanism.

Conclusions:

  • Thr(757) in Stat5a modulates transactivation potential.
  • This modulation is likely dependent on Stat5 dimer formation and/or nuclear translocation.
  • Phosphorylation of Thr(757) is not the primary regulatory mechanism.

Related Concept Videos